News
EazeBio and UC Santa Cruz partner to advance instrument-free diagnostic platform
EazeBio has announced a strategic partnership with the University of California, Santa Cruz (UC Santa Cruz) to advance and commercialize a groundbreaking instrument-free diagnostic platform. The collaboration will co-develop an innovative cortisol biosensor for stress and metabolic health testing, combining EazeBio’s expertise in affordable, scalable biotechnology with UC Santa Cruz’s deep research capabilities.
Advanced Lateral Flow Conference 2025 (AFLC)
We’re honored to share some exciting news!
Eazebio has been selected as one of only three finalists for the ALFC 2025 Innovation Award — recognizing breakthrough science that redefines what’s possible in healthcare. On October 14, our team will pitch on-stage, with the winner announced at the Closing Reception & Awards Ceremony on October 15.
We’re pioneering a new chemical biosensor platform — instrument-free, portable, and powered by Nobel Prize–inspired science — designed to deliver equitable access to diagnostics anywhere in the world. From metabolic stress to mental health, our goal is to empower prevention and early detection with simplicity and precision.
All India Institutes of Medical Sciences (AIIMS)
Why India?: Where Science Meets Humanity
India is where the story of global health equity is being rewritten.
Not in boardrooms — but in research labs, maternity wards, and mobile vans reaching the last mile.
This past month, as part of Eazebio’s work with AIIMS, the Indian Red Cross Society, and community health programs across Bhopal, I’ve seen what innovation truly means: listening first, then building.
11th Annual ADAM Global International Business Forum
Why Dubai?: Because Dubai is where East meets West
Dubai is a true crossroads for innovation, investment, and global collaboration. And yesterday, it was the stage for the 11th Annual ADAM International Business Forum, where I had the honor of speaking on the panel:
“Health Without Borders: How the East is Reshaping Global Healthcare Access, Innovation, and Investment.”
We're proud to partner with Turquoise Biotechnologies as their Innovation Ally
This collaboration aligns perfectly with our shared vision—leveraging cutting-edge exosomes and biomarker insights to deliver hyper-personalized, targeted therapies that go beyond traditional approaches and truly revolutionize patient care.
Official partnership with the Golden State Obesity Society (GSOS) as an Innovation Partner
This partnership reflects our mission to move from one-size-fits-all care to personalized, biomarker-driven solutions that improve patient outcomes. And it showcases how our platform is built to adapt across key areas—from metabolic health and post-surgical recovery to autoimmune resilience and beyond.
PRECISION MEDICINE WORLD CONFERENCE (PMWC) -FEB 5-7
Revolutionizing Women's Health: Precision Medicine Meets Empowerment
Discover how Eazebio is pioneering next-generation diagnostics to transform women's health. Founder Reem Mahrat highlights innovative approaches addressing unmet needs, from early detection to precision therapies, empowering women with cutting-edge solutions that redefine the future of personalized healthcare and advance equity in wellness worldwide.
Historic Moment as Burj CEO Awards 2024 Awardees Light Up Times Square Billboard
A historic milestone in the realm of business excellence unfolded as the Burj CEO 2024 Awardees, representing over 40 global brands, illuminated the iconic Times Square billboard in New York. This moment etched itself not only in the annals of business recognition but also in the hearts of all who bore witness to this grand tribute to achievement and leadership.
LET THE GAINS BEGIN
At Eazebio, we are on a mission to empower women’s health, championing groundbreaking solutions that address needs too long overlooked. But this dream—this moment—is about more than milestones. It’s about people.